Conatus Pharmaceuticals Inc. buy melinda
Start price
06.12.17
/
50%
€35.45
Target price
08.12.17
€36.98
Performance (%)
4.83%
End price
08.12.17
€37.16
Summary
This prediction ended on 08.12.17 with a price of €37.16. With a performance of 4.83%, the BUY prediction by melinda for Conatus Pharmaceuticals Inc. closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Conatus Pharmaceuticals Inc. | - | - | - | - |
iShares Core DAX® | -1.042% | 2.220% | 14.279% | 15.463% |
iShares Nasdaq 100 | -1.361% | 3.207% | 26.657% | 53.266% |
iShares Nikkei 225® | -0.044% | -1.680% | 5.941% | 4.271% |
iShares S&P 500 | -0.480% | 2.165% | 23.067% | 45.283% |
Comments by melinda for this prediction
In the thread Conatus Pharmaceuticals Inc. diskutieren
Biotechnologie und medizinische SecteurRecherche
A +
(Zielkurs erreicht)
Stopped prediction by melinda for Conatus Pharmaceuticals Inc.
Conatus Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.46
02.04.19
02.04.19
€19.84
30.10.19
30.10.19
-79.93%
30.10.19
30.10.19
Conatus Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€14.61
11.12.18
11.12.18
€27.06
09.01.19
09.01.19
29.63%
09.01.19
09.01.19
Conatus Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€43.48
06.02.17
06.02.17
€49.61
30.03.17
30.03.17
5.62%
30.03.17
30.03.17